Literature DB >> 1872803

Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradation.

D R van der Westhuyzen1, M L Stein, H E Henderson, A D Marais, A M Fourie, G A Coetzee.   

Abstract

The region of the low-density-lipoprotein (LDL) receptor showing sequence similarity to the epidermal-growth-factor (EGF) precursor is required for LDL binding and the acid-induced dissociation of ligand and receptor. We describe here a naturally occurring mutant LDL receptor, found in a patient with homozygous familial hypercholesterolaemia, which lacks the first two growth-factor-like repeats of the EGF-precursor-like ('homology') domain. The mutation in the receptor gene is a 2.5 kb deletion including exons 7 and 8. The molecular mass of the mutant receptor (145 kDa) was approx. 15 kDa smaller than the normal LDL receptor. The mutant receptors were derived from precursors (105 kDa) that apparently underwent normal processing. Fibroblasts from the patient had high-affinity binding sites for the the apolipoprotein E-containing ligand, beta VLDL, but did not bind LDL. In the presence of beta VLDL, receptors were rapidly degraded. The mutant receptors also displayed an abnormally rapid turnover, about four times faster than that of normal receptors, in the absence of ligand; this accelerated degradation accounted for the low level of expression of mutant receptors in up-regulated cells. These data support a role for the growth-factor-like repeats in the binding of LDL (but not beta VLDL) and in receptor recycling, and indicate that a normal rate of turnover of unoccupied receptors is dependent on the integrity of these segments of the protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1872803      PMCID: PMC1151296          DOI: 10.1042/bj2770677

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Transport-deficient mutations in the low density lipoprotein receptor. Alterations in the cysteine-rich and cysteine-poor regions of the protein block intracellular transport.

Authors:  V Esser; D W Russell
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

2.  Low-density-lipoprotein receptors in human fibroblasts are not degraded in lysosomes.

Authors:  L A Casciola; K I Grant; W Gevers; G A Coetzee; D R van der Westhuyzen
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

3.  First cysteine-rich repeat in ligand-binding domain of low density lipoprotein receptor binds Ca2+ and monoclonal antibodies, but not lipoproteins.

Authors:  I R van Driel; J L Goldstein; T C Südhof; M S Brown
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

4.  Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit.

Authors:  T Yamamoto; R W Bishop; M S Brown; J L Goldstein; D W Russell
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

5.  Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.

Authors:  E Leitersdorf; D R Van der Westhuyzen; G A Coetzee; H H Hobbs
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

6.  Low density lipoprotein receptor degradation is influenced by a mediator protein(s) with a rapid turnover rate, but is unaffected by receptor up- or down-regulation.

Authors:  L A Casciola; D R van der Westhuyzen; W Gevers; G A Coetzee
Journal:  J Lipid Res       Date:  1988-11       Impact factor: 5.922

7.  Effect of inhibiting N-glycosylation on the stability and binding activity of the low density lipoprotein receptor.

Authors:  I Filipovic
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

8.  Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins.

Authors:  J Lippincott-Schwartz; J S Bonifacino; L C Yuan; R D Klausner
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

9.  Analysis of a recycling-impaired mutant of low density lipoprotein receptor in familial hypercholesterolemia.

Authors:  Y Miyake; S Tajima; T Funahashi; A Yamamoto
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

Review 10.  Molecular basis of familial hypercholesterolemia.

Authors:  D W Russell; V Esser; H H Hobbs
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb
View more
  11 in total

1.  Role of an intramolecular contact on lipoprotein uptake by the LDL receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochim Biophys Acta       Date:  2011-04-09

2.  PCSK9 function and physiology.

Authors:  Andrew S Peterson; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2008-07       Impact factor: 5.922

3.  PCSK9 function and physiology.

Authors:  Andrew S Peterson; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2008-03-28       Impact factor: 5.922

4.  Identification of roles for H264, H306, H439, and H635 in acid-dependent lipoprotein release by the LDL receptor.

Authors:  Hongyun Dong; Zhenze Zhao; Drake G LeBrun; Peter Michaely
Journal:  J Lipid Res       Date:  2016-11-28       Impact factor: 5.922

5.  Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.

Authors:  Kara N Maxwell; Edward A Fisher; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

6.  Mechanism of LDL binding and release probed by structure-based mutagenesis of the LDL receptor.

Authors:  Sha Huang; Lisa Henry; Yiu Kee Ho; Henry J Pownall; Gabby Rudenko
Journal:  J Lipid Res       Date:  2009-08-11       Impact factor: 5.922

7.  The role of calcium in lipoprotein release by the low-density lipoprotein receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

8.  Molecular basis for LDL receptor recognition by PCSK9.

Authors:  Hyock Joo Kwon; Thomas A Lagace; Markey C McNutt; Jay D Horton; Johann Deisenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

9.  Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome.

Authors:  Julia Flemming; Maike Marczenke; Ina-Maria Rudolph; Rikke Nielsen; Tina Storm; Ilsoe Christensen Erik; Sebastian Diecke; Francesco Emma; Thomas E Willnow
Journal:  Kidney Int       Date:  2020-03-24       Impact factor: 10.612

10.  Internalized PCSK9 dissociates from recycling LDL receptors in PCSK9-resistant SV-589 fibroblasts.

Authors:  My-Anh Nguyen; Tanja Kosenko; Thomas A Lagace
Journal:  J Lipid Res       Date:  2013-12-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.